Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-13

Clinical Trial Update: Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating testosterone replacement to treat fatigue in male patients with hypogonadism and advanced cancer completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-09-13